Z-2453-2015 Class II Terminated

Recalled by Becton, Dickinson And Company, BD Biosciences — San Jose, CA

FDA device recall Z-2453-2015 was initiated by Becton, Dickinson And Company, BD Biosciences on Jul 17, 2015 and is designated Class II. Reason for recall: Three lots of CD56 PE Cy 7, Catalog number 335809, contain a low amount of HLA-DR PE antibody which could result in an unexpected staining pattern. The recall status is terminated (terminated Mar 11, 2016). Affected quantity: 362 units.

Recall details

Product Type
Devices
Report Date
Sep 2, 2015
Initiation Date
Jul 17, 2015
Termination Date
Mar 11, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
362 units

Product description

BD CD56 PE Cy 7: NCAM16.2 ASR Analyte Specific Reagent, Catalog number 335809 Hematology: The CD 56 antigen promotes homophilic adhesion in neurons and may be involved in homophilic adhesion of NK cells.

Reason for recall

Three lots of CD56 PE Cy 7, Catalog number 335809, contain a low amount of HLA-DR PE antibody which could result in an unexpected staining pattern.

Distribution pattern

US Distribution and Internationally to Taiwan.

Code information

Catalog number 335809; Lot numbers 4300708, 4304864, 5013643; all with expiry dates of 31 OCT 2015

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2453-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2453-2015. Report a data issue: hello@regdatalab.com.